Does LENACAPAVIR Cause Off label use? 95 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 95 reports of Off label use have been filed in association with LENACAPAVIR (Sunlenca). This represents 18.9% of all adverse event reports for LENACAPAVIR.
95
Reports of Off label use with LENACAPAVIR
18.9%
of all LENACAPAVIR reports
4
Deaths
4
Hospitalizations
How Dangerous Is Off label use From LENACAPAVIR?
Of the 95 reports, 4 (4.2%) resulted in death, 4 (4.2%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENACAPAVIR. However, 95 reports have been filed with the FAERS database.
What Other Side Effects Does LENACAPAVIR Cause?
Injection site pain (58)
Injection site nodule (53)
Product use issue (49)
Labelled drug-drug interaction medication error (43)
Injection site discharge (41)
Product use in unapproved therapeutic environment (40)
Injection site mass (23)
Viral load increased (21)
Fatigue (20)
Death (18)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which LENACAPAVIR Alternatives Have Lower Off label use Risk?
LENACAPAVIR vs LENALIDOMIDE
LENACAPAVIR vs LENIOLISIB
LENACAPAVIR vs LENOGRASTIM
LENACAPAVIR vs LENVATINIB
LENACAPAVIR vs LEPONEX